Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-14
DOI
10.1038/s41598-019-53198-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Droplet digital PCR improves absolute quantification of viable lactic acid bacteria in faecal samples
- (2018) Guillaume Gobert et al. JOURNAL OF MICROBIOLOGICAL METHODS
- No unexpected CRISPR-Cas9 off-target activity revealed by trio sequencing of gene-edited mice
- (2018) Vivek Iyer et al. PLoS Genetics
- Prevention and Management of Bleeding Episodes in Children with Hemophilia
- (2018) Rolf C. R. Ljung PEDIATRIC DRUGS
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
- (2017) Tsukasa Ohmori et al. Scientific Reports
- Genome-editing technologies for gene correction of hemophilia
- (2016) Chul-Yong Park et al. HUMAN GENETICS
- Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
- (2016) Delia D’Avola et al. JOURNAL OF HEPATOLOGY
- Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair
- (2016) Xiangjun He et al. NUCLEIC ACIDS RESEARCH
- Current and future prospects for hemophilia gene therapy
- (2016) Peter Ward et al. Expert Review of Hematology
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Off-target mutations are rare in Cas9-modified mice
- (2015) Vivek Iyer et al. NATURE METHODS
- A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice
- (2014) E. S. Molina et al. HAEMOPHILIA
- Progress and challenges in the development of a cell-based therapy for hemophilia A
- (2014) M. E. Fomin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A guide to genome engineering with programmable nucleases
- (2014) Hyongbum Kim et al. NATURE REVIEWS GENETICS
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype
- (2013) J. I. Siner et al. BLOOD
- Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
- (2013) J. McIntosh et al. BLOOD
- The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals
- (2013) Jun Mimuro et al. JOURNAL OF MEDICAL VIROLOGY
- Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII
- (2013) T. Shahani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- In vitrocharacterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile
- (2012) S. Pahl et al. HAEMOPHILIA
- The History and Evolution of the Clinical Effectiveness of Haemophilia Type A Treatment: A Systematic Review
- (2012) Hector E. Castro et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Modern haemophilia care
- (2012) Erik Berntorp et al. LANCET
- Past, present and future of hemophilia: a narrative review
- (2012) Massimo Franchini et al. Orphanet Journal of Rare Diseases
- The Diagnosis and Management of Congenital Hemophilia
- (2012) Manuel Carcao SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia
- (2011) Robert G. Schaub BIOCHEMICAL PHARMACOLOGY
- Current Options and New Developments in the Treatment of Haemophilia
- (2011) Trisha Wong et al. DRUGS
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Codon optimization of human factor VIII cDNAs leads to high-level expression
- (2010) N. J. Ward et al. BLOOD
- A study of variations in the reported haemophilia A prevalence around the world
- (2009) J. S. STONEBRAKER et al. HAEMOPHILIA
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started